Simbidol Asset is a syringe containing 15 grams of product developed to support liver health. It is formulated to help improve liver function, promoting the general well-being of the animal. Its specific composition allows a targeted action in supporting the detoxification and regeneration processes of the liver, essential for maintaining the body's health.
The syringe is practical and simple to use, allowing accurate and stress-free administration for the animal. Thanks to its consistency and formulation, the product is easily administered, ensuring effective assimilation of the active ingredients.
The supplement can be used in various clinical situations, in particular those with liver problems or conditions that require metabolic and detoxifying support. Furthermore, it can be used as an adjuvant in the treatment of chronic or acute liver diseases.
Therapeutic Indications
Simbidol Asset is indicated for the treatment and support of conditions that compromise liver function. It is useful in cases of liver diseases of various origins, including inflammatory, degenerative or toxic processes that cause reduced liver function. Its action promotes the protection of liver cells and stimulates their regeneration, helping to improve the general state of the animal with liver problems.
The product is indicated in clinical situations that require an improvement in hepatic metabolism, such as metabolic pathologies, damage caused by environmental toxins or drugs, or chronic pathologies involving the organ. It can be used in a complementary manner to conventional medical therapies to improve prognosis and reduce the side effects of pharmacological treatments.
Furthermore, Simbidol Asset can be used as prevention in situations at risk of liver damage, such as metabolic stress, liver overload conditions or living environments with exposure to toxic factors. Regular use helps maintain optimal liver function, which is essential for general health and for managing the body's immune and detoxifying responses.
Composition
Simbidol Asset is formulated with a complex of active ingredients studied for effectiveness in liver support. The composition includes specific nutrient elements, enzymatic cofactors, amino acids and antioxidant molecules that work synergistically to protect and regenerate liver cells.
Among the main components we highlight substances that promote detoxification, the stabilization of cell membranes and the promotion of the synthesis of proteins essential for tissue regeneration. The excipients are chosen to guarantee stability, efficacy and ease of administration, preserving the organoleptic and functional characteristics of the product.
The formulation is free of harmful or irritating components, making Simbidol Asset suitable for use in animals of different species, in the prescribed doses, and in accordance with specific therapeutic needs. The product is made according to rigorous quality standards to ensure maximum safety and tolerability.
Contraindications
The use of Simbidol Asset is contraindicated in case of known hypersensitivity to one or more components of the formulation. In situations of allergies or previous adverse reactions to similar active ingredients, it is recommended to consult the veterinarian before starting administration.
It is not recommended to use the product in animals with health conditions that could alter normal metabolism or absorption, unless specifically evaluated and prescribed by a healthcare professional. In particular, it is important to avoid unauthorized use in subjects with severe or end-stage liver failure without careful monitoring.
Safety of the drug for the species
Simbidol Asset is formulated for safe use in the target species, provided that dosages and methods of administration are followed correctly. Its composition is designed to minimize the risk of side effects, while simultaneously ensuring effective support for liver function.
Despite this, it is necessary that administration takes place under veterinary supervision
